Insider Trading April 15, 2026 05:10 PM

Village Super Market EVP Sells $524,672 of VLGEA Stock

John Sumas disposes of 12,703 Class A shares as company posts dividend declaration and ongoing litigation unfolds

By Caleb Monroe VLGEA
Village Super Market EVP Sells $524,672 of VLGEA Stock
VLGEA

Village Super Market Inc. Executive Vice President and Secretary John Sumas sold 12,703 Class A shares on April 14, 2026, for a total of $524,672. The sale occurred at prices between $40.945 and $41.87. After the transaction Sumas retains 102,938 shares. The stock is trading at $41.22, with solid gains over recent periods and valuation metrics showing a low P/E and a market cap of $608 million. Separately, the company has declared quarterly dividends and is engaged in pending litigation with Wakefern Food Corp.

Key Points

  • John Sumas sold 12,703 Class A shares on April 14, 2026, for total proceeds of $524,672; prices ranged from $40.945 to $41.87.
  • After the sale, Sumas directly owns 102,938 Village Super Market shares; the stock trades at $41.22 with a 26% six-month gain and a 17% year-to-date return.
  • Village Super Market declared quarterly dividends (Class A: $0.25; Class B: $0.1625) payable April 23, 2026, and is involved in pending litigation with Wakefern Food Corp.

John Sumas, who serves as Executive Vice President and Secretary of Village Super Market Inc., reported the sale of 12,703 shares of the company's Class A Common Stock on April 14, 2026, in a Form 4 filing with the Securities and Exchange Commission.

The shares were disposed of in transactions priced between $40.945 and $41.87 per share, yielding aggregate proceeds of $524,672. Following the disposition, Sumas is listed as directly holding 102,938 shares of Village Super Market.


Market snapshot

At the time of the filing, Village Super Market's stock was trading at $41.22. The share price has gained 26% over the preceding six months and is ahead 17% year to date. Public valuation metrics included in the reporting show a price-to-earnings ratio of 10.83 and a market capitalization of $608 million. Analysis from InvestingPro referenced in the filing indicates the stock appears undervalued according to its Fair Value assessment and notes 11 additional tips and expanded financial metrics for deeper review.


Corporate actions and legal matters

The company’s Board of Directors recently declared a quarterly cash dividend of $0.25 per Class A common share and $0.1625 per Class B common share. These dividends are scheduled to be paid on April 23, 2026, to shareholders of record as of April 2, 2026.

Village Super Market is also involved in active litigation with Wakefern Food Corp. Wakefern has filed counterclaims and a third-party complaint in response to Village Super Market’s Second Amended Complaint and Jury Demand, which includes claims for punitive and other damages. The case, captioned Village Super Market, Inc., et al. v. Wakefern Food Corp., et al., is pending in the Superior Court of New Jersey, Law Division, Middlesex County.


Context for stakeholders

The Form 4 disclosure documents an insider sale and provides the exact transaction figures and the executive’s remaining direct holdings. The company’s contemporaneous corporate actions - the dividend declaration - and the disclosed legal proceedings appear alongside the trading activity in the public record.

Readers seeking additional valuation context can note the P/E and market-cap figures reported here, as well as the InvestingPro Fair Value assessment cited in the filing.

Risks

  • Ongoing litigation with Wakefern Food Corp., including counterclaims and a third-party complaint, creates legal uncertainty for the company - impacts legal and retail sectors.
  • Insider selling may raise questions for investors about insider liquidity needs or portfolio rebalancing, which can affect investor perception - impacts equity markets and retail investor sentiment.
  • Dividend payments and corporate disclosures coincide with litigation and insider transactions, which could complicate near-term investor analysis of the company’s financial position - impacts shareholder decision-making and financial services sector.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026